Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-23T22:40:51.827Z Has data issue: false hasContentIssue false

RE: ‘Shock tactics’, ethics and fear: an academic and personal perspective on the case against electroconvulsive therapy

Published online by Cambridge University Press:  21 November 2022

Tania Gergel*
Affiliation:
Senior Research Fellow, King's College London Institute of Psychiatry Psychology and Neuroscience. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Type
Correspondence
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists

9 June 2022

Author's reply: I thank Dr Yeomans for his letter and will answer his concerns point by point. Yeomans’ suggestion that there is no evidence to support the effectiveness of ECT is based on a review by Read et al summarising details about a handful of placebo-based studies which are now between 60 and 40 years old.Reference Read, Kirsch and McGrath1 As Meechan et al clearly explain, the selected studies ‘would not meet contemporary standards of evidence-based medicine’,Reference Meechan, Laws, Young, McLoughlin and Jauhar2 and Yeoman's letter ignores substantial recent evidence-based research, including randomised controlled trials, showing the benefits of ECT versus active comparators.Reference Meechan, Laws, Young, McLoughlin and Jauhar2,Reference Kirov, Jauhar, Sienaert, Kellner and McLoughlin3 In addition, there is significant research showing ECT's physical safety.Reference Kirov, Jauhar, Sienaert, Kellner and McLoughlin3,Reference Gergel, Howard, Lawrence and Seneviratne4

He also suggests that I ‘generalise from personal experience’ rather than using a ‘scientific approach’. My personal experience recounted here is by no means a replacement for science, and Yeomans clearly overlooks the fact that all my key points about ECT are supported by references to the scientific literature. I chose to include my own experiences as an illustrative vignette, the authenticity of which may be harder for ECT critics to dismiss, given that I am describing my own case. As the stigma surrounding ECT makes it difficult for ECT recipients to be open about having received treatment, I aimed to offer some responses to questions often raised about experiencing this treatment.

Yeomans refers to the point that some psychiatrists have strong reservations about ECT, without providing any references or evidence for this claim. Neither Read nor any co-author of the review cited by Yeomans is a psychiatrist. In fact, in relation to his 2020 review, Read has himself written ‘I am indeed biased against ECT’.Reference Read5 However, even if Yeomans’ claim is true, it certainly does not invalidate the strong general support amongst psychiatrists and the international medical community for ECT. Moreover, studies have shown that clinicians’ concerns about ECT can be assuaged through experience of seeing ECT in practice.Reference Pranjkovic, Degmecic, Medic Flajsman, Gazdag, Ungvari and Kuzman6

Finally, a common trope within ECT critiques suggests some global psychiatric conspiracy. What Yeomans and the other ECT critics fail to point out is that ECT is a multidisciplinary process, involving not only psychiatrists, but also anaesthetists, operating department practitioners and mental health nurses. In the UK, the National Association of Lead Nurses in ECT has an underlying philosophy that ‘ECT is one of a variety of beneficial treatments available and should be viewed as part of a holistic process’7 and have championed the use of nurse-led ECT. As I make clear in my article, ECT is not always successful. However, in general, those who work in ECT clinics see large numbers of patients experience dramatic recoveries from the most severe states of mental illness, which in itself convinces them of its effectiveness. Combined with a strong evidence base, Paris's claim that ECT is ‘one of the most effective treatments in all of psychiatry’ is understandable and not, as Yeomans says, ‘remarkable’ or out of place in ‘a rigorous scientific journal’.Reference Paris8

Declaration of interest

None

References

Read, J, Kirsch, I, McGrath, L. Electroconvulsive therapy for depression: a review of the quality of ECT versus sham ECT trials and meta-analyses. Ethical Hum Psychol Psychiatry 2020; 21(2): 64.CrossRefGoogle Scholar
Meechan, CF, Laws, KR, Young, AH, McLoughlin, DM, Jauhar, S. A critique of narrative reviews of the evidence-base for ECT in depression. Epidemiol Psychiatr Sci 2022; 31: e10.Google ScholarPubMed
Kirov, G, Jauhar, S, Sienaert, P, Kellner, CH, McLoughlin, DM. Electroconvulsive therapy for depression: 80 years of progress. Br J Psychiatry 2021; 219(5): 594–7.Google ScholarPubMed
Gergel, T, Howard, R, Lawrence, R, Seneviratne, T. Time to acknowledge good electroconvulsive therapy research. Lancet Psychiatry 2021; 8(12): 1032–3.CrossRefGoogle ScholarPubMed
Read, J. No evidence that ECT works for depression – new research. The Conversation, 2020. Available from: https://theconversation.com/no-evidence-that-ect-works-for-depression-new-research-139938.Google Scholar
Pranjkovic, T, Degmecic, D, Medic Flajsman, A, Gazdag, G, Ungvari, GS, Kuzman, MR. Observing electroconvulsive therapy changes students’ attitudes: a survey of Croatian medical students. J ECT 2017; 33(1): 26–9.CrossRefGoogle ScholarPubMed
Paris, J. Why electroconvulsive therapy still carries a stigma. Br J Psychiatry 2022; 220(3): 113–4.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.